Autolus Therapeutics (AUTL) Other Gross PP&E Adjustments (2017 - 2025)
Autolus Therapeutics (AUTL) has disclosed Other Gross PP&E Adjustments for 9 consecutive years, with -$54.1 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Other Gross PP&E Adjustments fell 15.09% year-over-year to -$54.1 million, compared with a TTM value of -$54.1 million through Sep 2025, down 15.09%, and an annual FY2024 reading of -$57.4 million, up 14.87% over the prior year.
- Other Gross PP&E Adjustments was -$54.1 million for Q3 2025 at Autolus Therapeutics, down from -$51.7 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$8.7 million in Q4 2021 and bottomed at -$67.4 million in Q4 2023.
- Average Other Gross PP&E Adjustments over 5 years is -$33.4 million, with a median of -$30.0 million recorded in 2023.
- The sharpest move saw Other Gross PP&E Adjustments soared 83.82% in 2021, then tumbled 361.82% in 2023.
- Year by year, Other Gross PP&E Adjustments stood at -$8.7 million in 2021, then crashed by 68.35% to -$14.6 million in 2022, then crashed by 361.82% to -$67.4 million in 2023, then rose by 14.87% to -$57.4 million in 2024, then grew by 5.78% to -$54.1 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for AUTL at -$54.1 million in Q3 2025, -$51.7 million in Q2 2025, and -$12.5 million in Q1 2025.